TY - JOUR
T1 - Relative frequency and morphology of cancers in STK11 mutation carriers
AU - Lim, Wendy
AU - Olschwang, Sylviane
AU - Keller, Josbert J.
AU - Westerman, Anne Marie
AU - Menko, Fred H.
AU - Boardman, Lisa A.
AU - Scott, Rodney J.
AU - Trimbath, Jill
AU - Giardiello, Francis M.
AU - Gruber, Stephen B.
AU - Gille, Johan J.P.
AU - Offerhaus, G. Johan A.
AU - De Rooij, Felix W.M.
AU - Wilson, J. H.Paul
AU - Spigelman, Allan D.
AU - Phillips, Robin K.S.
AU - Houlston, Richard S.
N1 - Funding Information:
Supported by Cancer Research U.K., the Clayton Fund, the John G. Rangos Sr Charitable Fund at Johns Hopkins Hospital, and the Hunter Medical Research Institute at the John Hunter Hospital. W.L. received a grant from the Epsom Hospital National Health Service Trust Gastroenterology Research and Development Fund.
PY - 2004/6
Y1 - 2004/6
N2 - Background & Aims: There is limited data on the spectrum and risk for cancer associated with germline serine/threonine protein kinase 11 (STK11) mutations that cause Peutz-Jeghers syndrome (PJS). Methods: We analyzed the incidence of cancer in 240 individuals with PJS possessing germline mutations in STK11. Results: Fifty-four cancers were found among carriers. Overall, the risk for developing cancer at ages 20, 30, 40, 50, 60, and 70 years was 1%, 3%, 19%, 32%, 63%, and 81%, respectively. Kaplan-Meier analysis showed similar cancer risks between missense and truncating mutation carriers (log-rank χ2 = 2.48; P = 0.12). There was some evidence that mutations in exon 3 of STK11 were associated with a higher cancer risk than mutations within other regions of the gene. We found no difference in overall cancer risk between male and female carriers (log-rank χ2 = 1.31; P = 0.25) or between familial and sporadic cases (log-rank χ2 = 1.16, with 1 df; P = 0.28). The most common cancers represented were gastrointestinal in origin-gastroesophageal, small bowel, colorectal, and pancreatic-and the risk for these cancers at ages 30, 40, 50, and 60 years was 1%, 10%, 18%, and 42%, respectively. In women, the risk for breast cancer was substantially increased, being 32% by age 60 years. Conclusions: These results quantitatively show the spectrum of cancer risk associated with STK11 germline mutations in the context of PJS and provide a valuable reference for defining surveillance regimens.
AB - Background & Aims: There is limited data on the spectrum and risk for cancer associated with germline serine/threonine protein kinase 11 (STK11) mutations that cause Peutz-Jeghers syndrome (PJS). Methods: We analyzed the incidence of cancer in 240 individuals with PJS possessing germline mutations in STK11. Results: Fifty-four cancers were found among carriers. Overall, the risk for developing cancer at ages 20, 30, 40, 50, 60, and 70 years was 1%, 3%, 19%, 32%, 63%, and 81%, respectively. Kaplan-Meier analysis showed similar cancer risks between missense and truncating mutation carriers (log-rank χ2 = 2.48; P = 0.12). There was some evidence that mutations in exon 3 of STK11 were associated with a higher cancer risk than mutations within other regions of the gene. We found no difference in overall cancer risk between male and female carriers (log-rank χ2 = 1.31; P = 0.25) or between familial and sporadic cases (log-rank χ2 = 1.16, with 1 df; P = 0.28). The most common cancers represented were gastrointestinal in origin-gastroesophageal, small bowel, colorectal, and pancreatic-and the risk for these cancers at ages 30, 40, 50, and 60 years was 1%, 10%, 18%, and 42%, respectively. In women, the risk for breast cancer was substantially increased, being 32% by age 60 years. Conclusions: These results quantitatively show the spectrum of cancer risk associated with STK11 germline mutations in the context of PJS and provide a valuable reference for defining surveillance regimens.
UR - http://www.scopus.com/inward/record.url?scp=2942527434&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2942527434&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2004.03.014
DO - 10.1053/j.gastro.2004.03.014
M3 - Article
C2 - 15188174
AN - SCOPUS:2942527434
SN - 0016-5085
VL - 126
SP - 1788
EP - 1794
JO - Gastroenterology
JF - Gastroenterology
IS - 7
ER -